Mario C Raviglione (Mario Raviglione)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

BMJ global health

Journal of medical Internet research

Journal of medical virology

PLoS medicine

University of Milan

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Milan Apr 01 2018

Italy

Professor :: Global Health

World Health Organization Aug 01 1991 - Nov 30 2017

Switzerland

Director (2003-17), Coordinator (1997-2003), Medical Officer (1991-7) :: Global TB Programme

Beth Israel Deaconess Medical Center Jul 01 1990 - Jun 30 1991

United States

Clinical Research Fellow :: Infectious Diseases

Cabrini Medical Center Jul 01 1984 - Jun 30 1990

United States

Resident, Chief Resident, Fellow :: Internal Medicine & Infectious Diseases

Publications

Simone Villa, Pierpaolo de Colombani, Lucia Dall'Olio, Giuliano Gargioni, Mario C Raviglione
Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis. BMJ global health 9 (4) (2024)
Simone Villa, Pierpaolo de Colombani, Lucia Dall'Olio, Giuliano Gargioni, Mario C Raviglione
Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis. BMJ global health 9 (4) (2024)
Simone Villa, Pierpaolo de Colombani, Lucia Dall'Olio, Giuliano Gargioni, Mario C Raviglione
Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis. BMJ global health 9 (4) (2024)
Simone Villa, Pierpaolo de Colombani, Lucia Dall'Olio, Giuliano Gargioni, Mario C Raviglione
Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis. BMJ global health 9 (4) (2024)
Simone Villa, Pierpaolo de Colombani, Lucia Dall'Olio, Giuliano Gargioni, Mario C Raviglione
Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis. BMJ global health 9 (4) (2024)
Silvia Bianchi, Clara Fappani, Maria Gori, Marta Canuti, Daniela Colzani, Maria Cristina Monti, Camilla Torriani, Mario C Raviglione, Gian Vincenzo Zuccotti, Elisabetta Tanzi, Antonella Amendola
Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017-2022. Virology journal 20 (1) (2023)
Raquel Villar-Hernández, Arash Ghodousi, Olha Konstantynovska, Raquel Duarte, Christoph Lange, Mario C Raviglione
Tuberculosis: current challenges and beyond. Breathe (Sheffield, England) 19 (1) (2023)
Elisabetta Tanzi, Silvia Bianchi, Clara Fappani, Maria Gori, Daniela Colzani, Ilaria Passera, Camilla Tincati, Marta Canuti, Mario C Raviglione, Antonella Amendola
Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries. Journal of medical virology 95 (5) (2023)
Paolo Rodi, Werner Obermeyer, Ariel Pablos-Mendez, Andrea Gori, Mario C Raviglione
Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study. PLoS medicine 19 (1) (2022)
Marta Canuti, Silvia Bianchi, Otto Kolbl, Sergei L Kosakovsky Pond, Sudhir Kumar, Maria Gori, Clara Fappani, Daniela Colzani, Elisa Borghi, Gian Vincenzo Zuccotti, Mario C Raviglione, Elisabetta Tanzi, Antonella Amendola
Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence? BMJ global health 7 (3) (2022)
Yejin Lee, Mario C Raviglione, Antoine Flahault
Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review. Journal of medical Internet research 22 (2) (2020)

Mario C Raviglione.css-eqlu8i{font-size:small;padding-left:4px;} (Mario Raviglione)

Publication Activity (10 Years)

Top Topics

Top Venues

Mario C Raviglione (Mario Raviglione)